On CNBC's "Mad Money Lightning Round," Jim Cramer said AbbVie Inc. (NYSE:ABBV) is doing "very, very well." However, he added that Abbott Laboratories (NYSE:ABT) remains his favorite in the group right ...
We use essential cookies to make our site work. With your consent, we may also use non-essential cookies to improve user experience and analyze website traffic. By clicking “Accept,” you agree to our ...
We use essential cookies to make our site work. With your consent, we may also use non-essential cookies to improve user experience and analyze website traffic. By clicking “Accept,” you agree to our ...